These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 4069516)
1. [Anticoagulants, thrombolytics and platelet aggregation inhibitors in the complex therapy of thrombosis of the central retinal vein and its branches]. Krasnikov PG; Permiakova VV Oftalmol Zh; 1985; (5):289-93. PubMed ID: 4069516 [No Abstract] [Full Text] [Related]
2. [First report on experience with the combined treatment of thrombosis of the central retinal vein or its branches with an aggregation inhibitor (Colfarit) (author's transl)]. Weimershaus HJ Klin Monbl Augenheilkd; 1973 Dec; 163(6):765-8. PubMed ID: 4274923 [No Abstract] [Full Text] [Related]
6. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
7. [Treatment of thrombosis of the central retinal vein by anticoagulants or by thrombolytics]. den Ottolander GJ; Craandyk A Phlebologie; 1970; 23(1):73-4. PubMed ID: 5437547 [No Abstract] [Full Text] [Related]
8. [Pathogenetic treatment of acute obstruciton of the retinal vessels]. Shul'pina NB; Neskreba EF; Ushakova GV Vestn Oftalmol; 1974; (6):29-32. PubMed ID: 4446224 [No Abstract] [Full Text] [Related]
9. [Use of platelet-function inhibitors in arterial thromboses]. Reuter H ZFA (Stuttgart); 1977 May; 53(15):861-5. PubMed ID: 883380 [No Abstract] [Full Text] [Related]
10. [New agents and challenges in the antithrombotic management of arterial diseases]. Udvardy M; Rák K Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617 [TBL] [Abstract][Full Text] [Related]
11. [Antithrombotic therapy]. David JL Rev Med Liege; 1980 May; 35(9):363-72. PubMed ID: 7466058 [No Abstract] [Full Text] [Related]
12. Impending central retinal vein occlusion associated with increased platelet aggregability. Priluck IA Ann Ophthalmol; 1979 Jan; 11(1):79-84. PubMed ID: 420479 [TBL] [Abstract][Full Text] [Related]
13. [Current attitude of the ophthalmologist in the management of an acute circulatory accident in the fundus oculi]. Algan B; Henry M; Leyder Ch; Marchal H Annee Ther Clin Ophtalmol; 1973; 24():361-7. PubMed ID: 4614696 [No Abstract] [Full Text] [Related]
14. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk. Freudenberger RS; Fuster V Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540 [No Abstract] [Full Text] [Related]
15. [Considerations on various types of therapy of occlusion of the central retinal vein]. Cambiaggi A; Giacca S; Lepori R Minerva Oftalmol; 1966; 8(5):164-72. PubMed ID: 5991428 [No Abstract] [Full Text] [Related]
16. The influence of ticlopidine on the natural course of retinal vein occlusion. Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648 [TBL] [Abstract][Full Text] [Related]
17. [Can one treat intravascular thromboses with thrombolytics without risk?]. Josso F; Dreyfus B; Samama M; Péquignot H Presse Med (1893); 1968 May; 76(22):1067-70. PubMed ID: 5648679 [No Abstract] [Full Text] [Related]